In ESCC, a previous report showed that STX6 was upregulated and significantly associated with tumor size, histologic differentiation, lymph node involvement, and the extent of tumor invasion; in addition, STX6 activity was associated with ESCC progression.27 The gene discussed is STX6; the disease is neoplasm.